Amgen Investors
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Total Funding:
28500000000.0
Acquisitions Number:
Made Acquisitions
Headquarters:
Thousand Oaks, California, United States
Funding Status:
IPO
Employee Number:
10001+
Estimated Revenue:
$10B+
Investment Stage:
N/A
Last Funding Type:
Post-IPO Debt
Number Of Exists:
6
Technology:
Space Medicine
Investor Type:
Undisclosed
Last Funding Date:
2022-12-12
Founded Date:
1980-01-01
Industry:
Pharma